Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Weiss: Protection by Neutralizing Antibodies |
| Strategy: | Protein & peptide vaccines |
| Study Type: | Pre-Clinical Non-NHP |
| Species: | Guinea Pig |
| Stage: | Assays Completed |
| Study Start Date: | 2011-11-03 |
| Study Made Public: | 2012-09-12 |
Title
Immunization with liposomal gp41-MPER antigens elicits neutralizing antibodies to HIV-1
Description
CAVD 274 is a guinea pig study that employs two different gp41 proteoliposome formulations that contain fusion intermediate conformations of gp41 fragments inserted or attached to liposomes.
Sign in to see full information about this study and to download study data.
Products
Env gp140 CA018 V3 mimetic gp41 liposome A gp41 liposome B Liposome A Liposome BIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.